Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

1.

Changes in cancer cell metabolism revealed by direct sample analysis with MALDI mass spectrometry.

Pirman DA, Efuet E, Ding XP, Pan Y, Tan L, Fischer SM, DuBois RN, Yang P.

PLoS One. 2013 Apr 26;8(4):e61379. doi: 10.1371/journal.pone.0061379. Print 2013.

PMID:
23658609
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The role of cytochrome c oxidase subunit Va in non-small cell lung carcinoma cells: association with migration, invasion and prediction of distant metastasis.

Chen WL, Kuo KT, Chou TY, Chen CL, Wang CH, Wei YH, Wang LS.

BMC Cancer. 2012 Jun 29;12:273. doi: 10.1186/1471-2407-12-273.

PMID:
22748147
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Formation and antiproliferative effect of prostaglandin E(3) from eicosapentaenoic acid in human lung cancer cells.

Yang P, Chan D, Felix E, Cartwright C, Menter DG, Madden T, Klein RD, Fischer SM, Newman RA.

J Lipid Res. 2004 Jun;45(6):1030-9. Epub 2004 Mar 1.

PMID:
14993240
[PubMed - indexed for MEDLINE]
Free Article
4.

Prostaglandin E3 metabolism and cancer.

Yang P, Jiang Y, Fischer SM.

Cancer Lett. 2014 Jun 28;348(1-2):1-11. doi: 10.1016/j.canlet.2014.03.010. Epub 2014 Mar 18. Review.

PMID:
24657656
[PubMed - indexed for MEDLINE]
5.

Proanthocyanidins inhibit in vitro and in vivo growth of human non-small cell lung cancer cells by inhibiting the prostaglandin E(2) and prostaglandin E(2) receptors.

Sharma SD, Meeran SM, Katiyar SK.

Mol Cancer Ther. 2010 Mar;9(3):569-80. doi: 10.1158/1535-7163.MCT-09-0638. Epub 2010 Feb 9. Erratum in: Mol Cancer Ther. 2012 Sep;11(9):2072-3.

PMID:
20145019
[PubMed - indexed for MEDLINE]
Free Article
6.

Detection and identification of potential biomarkers of non-small cell lung cancer.

Yang Y, Zhao S, Fan Y, Zhao F, Liu Q, Hu W, Liu D, Fan K, Wang J, Wang J.

Technol Cancer Res Treat. 2009 Dec;8(6):455-66.

PMID:
19925029
[PubMed - indexed for MEDLINE]
7.

Lipid MALDI profile classifies non-small cell lung cancers according to the histologic type.

Lee GK, Lee HS, Park YS, Lee JH, Lee SC, Lee JH, Lee SJ, Shanta SR, Park HM, Kim HR, Kim IH, Kim YH, Zo JI, Kim KP, Kim HK.

Lung Cancer. 2012 May;76(2):197-203. doi: 10.1016/j.lungcan.2011.10.016. Epub 2011 Nov 17.

PMID:
22099218
[PubMed - indexed for MEDLINE]
8.

Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation.

Hattar K, Savai R, Subtil FS, Wilhelm J, Schmall A, Lang DS, Goldmann T, Eul B, Dahlem G, Fink L, Schermuly RT, Banat GA, Sibelius U, Grimminger F, Vollmer E, Seeger W, Grandel U.

Cancer Immunol Immunother. 2013 Feb;62(2):309-20. doi: 10.1007/s00262-012-1341-2. Epub 2012 Aug 26.

PMID:
22923191
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Induction of cytosolic phospholipase A2 by oncogenic Ras in human non-small cell lung cancer.

Heasley LE, Thaler S, Nicks M, Price B, Skorecki K, Nemenoff RA.

J Biol Chem. 1997 Jun 6;272(23):14501-4.

PMID:
9169405
[PubMed - indexed for MEDLINE]
Free Article
10.

Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE2 and PGE3 and alteration of Akt phosphorylation.

Yang P, Cartwright C, Chan D, Ding J, Felix E, Pan Y, Pang J, Rhea P, Block K, Fischer SM, Newman RA.

Mol Carcinog. 2014 Jul;53(7):566-77. doi: 10.1002/mc.22008. Epub 2013 Jan 31.

PMID:
23371504
[PubMed - in process]
11.

The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer.

Kumar MS, Hancock DC, Molina-Arcas M, Steckel M, East P, Diefenbacher M, Armenteros-Monterroso E, Lassailly F, Matthews N, Nye E, Stamp G, Behrens A, Downward J.

Cell. 2012 Apr 27;149(3):642-55. doi: 10.1016/j.cell.2012.02.059.

PMID:
22541434
[PubMed - indexed for MEDLINE]
Free Article
12.

Inhibition of RalA signaling pathway in treatment of non-small cell lung cancer.

Male H, Patel V, Jacob MA, Borrego-Diaz E, Wang K, Young DA, Wise AL, Huang C, Van Veldhuizen P, O'Brien-Ladner A, Williamson SK, Taylor SA, Tawfik O, Esfandyari T, Farassati F.

Lung Cancer. 2012 Aug;77(2):252-9. doi: 10.1016/j.lungcan.2012.03.007. Epub 2012 Apr 10.

PMID:
22498113
[PubMed - indexed for MEDLINE]
13.

Pachymic acid inhibits cell growth and modulates arachidonic acid metabolism in nonsmall cell lung cancer A549 cells.

Ling H, Jia X, Zhang Y, Gapter LA, Lim YS, Agarwal R, Ng KY.

Mol Carcinog. 2010 Mar;49(3):271-82. doi: 10.1002/mc.20597.

PMID:
19918789
[PubMed - indexed for MEDLINE]
14.

NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer.

Hughes D, Otani T, Yang P, Newman RA, Yantiss RK, Altorki NK, Port JL, Yan M, Markowitz SD, Mazumdar M, Tai HH, Subbaramaiah K, Dannenberg AJ.

Cancer Prev Res (Phila). 2008 Sep;1(4):241-9. doi: 10.1158/1940-6207.CAPR-08-0055.

PMID:
19138967
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras transgenic mice by omics approaches.

Lee S, Kang J, Cho M, Seo E, Choi H, Kim E, Kim J, Kim H, Kang GY, Kim KP, Park YH, Yu DY, Yum YN, Park SN, Yoon DY.

Int J Oncol. 2009 Jan;34(1):161-72.

PMID:
19082487
[PubMed - indexed for MEDLINE]
16.

Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells.

Lee HY, Moon H, Chun KH, Chang YS, Hassan K, Ji L, Lotan R, Khuri FR, Hong WK.

J Natl Cancer Inst. 2004 Oct 20;96(20):1536-48.

PMID:
15494604
[PubMed - indexed for MEDLINE]
Free Article
17.

Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.

Zhu CQ, Popova SN, Brown ER, Barsyte-Lovejoy D, Navab R, Shih W, Li M, Lu M, Jurisica I, Penn LZ, Gullberg D, Tsao MS.

Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11754-9. Epub 2007 Jun 28.

PMID:
17600088
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.

Kanou T, Oneyama C, Kawahara K, Okimura A, Ohta M, Ikeda N, Shintani Y, Okumura M, Okada M.

Mol Cancer Res. 2011 Jan;9(1):103-14. doi: 10.1158/1541-7786.MCR-10-0340. Epub 2010 Dec 14.

PMID:
21156787
[PubMed - indexed for MEDLINE]
Free Article
19.

Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.

Moody TW, Switzer C, Santana-Flores W, Ridnour LA, Berna M, Thill M, Jensen RT, Sparatore A, Del Soldato P, Yeh GC, Roberts DD, Giaccone G, Wink DA.

Lung Cancer. 2010 May;68(2):154-60. doi: 10.1016/j.lungcan.2009.06.012. Epub 2009 Jul 23.

PMID:
19628293
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer.

Liu Y, Marks K, Cowley GS, Carretero J, Liu Q, Nieland TJ, Xu C, Cohoon TJ, Gao P, Zhang Y, Chen Z, Altabef AB, Tchaicha JH, Wang X, Choe S, Driggers EM, Zhang J, Bailey ST, Sharpless NE, Hayes DN, Patel NM, Janne PA, Bardeesy N, Engelman JA, Manning BD, Shaw RJ, Asara JM, Scully R, Kimmelman A, Byers LA, Gibbons DL, Wistuba II, Heymach JV, Kwiatkowski DJ, Kim WY, Kung AL, Gray NS, Root DE, Cantley LC, Wong KK.

Cancer Discov. 2013 Aug;3(8):870-9. doi: 10.1158/2159-8290.CD-13-0015. Epub 2013 May 28.

PMID:
23715154
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk